Clinical research

Please check for your eligibility to pursue Advanced programme in clinical research and pharmacovigilance course from the criteria mentioned below:
Eligibility Criteria:
In order to pursue a career in pharmacovigilance, the minimum eligibility criteria to apply for the course is:
A postgraduate or graduate degree in Bioscience/Life Sciences (with any of the following subjects: Botany, Zoology, Biochemistry, Microbiology, Genetics, Biotech) with at least 50% marks in aggregate
A postgraduate or graduate degree with Chemistry as a subject with at least 50% marks in aggregate
A postgraduate or graduate degree in Pharmacy or Pharmaceutical Sciences
A postgraduate or graduate degree in Medicine
The selection process is based on merit. Admission is granted only to students who have cleared a written examination and a personal interview. Job Prospects:
There is no shortage of jobs in this field as high-quality pharmacovigilance practice makes for good business dealing. Students in this field can get jobs in various pharmaceutical companies and earn attractive and handsome packages. With new drugs being made every day, a career in pharmacovigilance has good prospects. Regards.

Scope of M.Sc. In Clinical Research in India:
Masters in clinical Research is still not a very popular course among students. The primary reason for low demand is the low level of awareness about the discipline and its job prospects. But those who are studying and working in pharmaceuticals are surely well versed with high good it is as a career. It has a very good scope and a very good pay scale. Here I will give you some details of Scope of Masters in clinical research. Scope of Masters in Clinical Research:
Indian Pharmaceutical Industry is a Huge one. The Industry requires well-trained and specialised clinical research professionals, whereas the number of students passing out each year in the discipline is far less than the demand. You have jobs in top companies like
Ranbaxy
Dr. Reddy's Laboratory
Jonson and Jonson
Cipla etc.